The Effects of EXOPULSE Mollii Suit on Motor Functions in Patients With Stroke (EXOSTROKE)
Spasticity is a common and debilitating complication in neurological conditions such as multiple sclerosis, cerebral palsy, and stroke. Stroke, a leading cause of global disability and death, occurs when blood flow to the brain is disrupted, causing neuronal damage. Approximately 80% of strokes are ischemic, with 20% being hemorrhagic. Several factors, including age, sex, vascular conditions, and lifestyle choices, increase the risk of stroke. Spasticity affects 19-28% of stroke survivors in the short term and up to 46% in the long term, severely impacting mobility and quality of life. Management typically involves pharmacological and nonpharmacological interventions, though these often have limited effectiveness and side effects. In this context, non-invasive techniques like transcutaneous stimulation with the EXOPULSE Mollii suit may offer a valuable alternative for managing spasticity and its associated symptoms.
• Age between 18 and 75 years.
• Having a clinical diagnosis of stroke for at least three months.
• Being able to walk freely or with the need of support (modified Rankin score
⁃ 4).
• Being a French speaker, able to understand verbal instructions, and affiliated. with the national health insurance (sécurité social).
• Having spasticity with a score of at least 1+ on the MAS.
• Having a Berg Balance Scale score ≤46 associated across the literature with a risk of fall.